← Back to Search

Online Intervention for HIV

N/A

Waitlist Available

Led By Kate Muessig, PhD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-month, 6-month, 9-month, and 12-month follow-up assessments

Awards & highlights

Study Summary

This trial is testing whether an online intervention can help reduce the negative impact of multiple stigmas on HIV-related outcomes for young Black and Latino men who have sex with men and transgender women.

Who is the study for?

This trial is for young Black and/or Latino men who have sex with men and transgender women, aged 15-29, living in the U.S., who've had condomless anal sex with a man in the last 6 months. Participants must have internet access and own or regularly use a smartphone or laptop/tablet.Check my eligibility

What is being tested?

The study tests an online intervention designed to provide social support, HIV testing information, and resources tailored to reduce stigma's impact on HIV outcomes among participants. It's a randomized trial with three groups to compare different approaches.See study design

What are the potential side effects?

Since this trial involves social support and informational resources rather than medical treatments, traditional physical side effects are not expected. However, emotional or psychological responses may vary based on individual experiences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-month, 6-month, 9-month, and 12-month follow-up assessments

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-month, 6-month, 9-month, and 12-month follow-up assessments

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month, 6-month, 9-month, and 12-month follow-up assessments for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HIV Testing Behavior

Change in Viral Suppression

Secondary outcome measures

Changes in Pre-Exposure Prophylaxis (PrEP) uptake

Changes in Treatment Adherence

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Peer-referred HMP network armExperimental Treatment3 Interventions

Participants randomized to Intervention Arm 2 (peer-created network) will be enrolled into a parallel (but separate) version of HMP 2.0. The only difference between the two intervention arms is that the peer-referred HMP network arm will allow participants to refer and enroll 2 peers of their choosing into the study.

Group II: HMP 2.0 ArmExperimental Treatment3 Interventions

Participants in this experimental arm will receive access to HMP 2.0, an interactive site that includes a Knowledge Center focused on HIV prevention content, interactive forums, and a provider question & answer platform.

Group III: Information-Only ArmActive Control2 Interventions

The HMP 2.0 Information-Only Control Arm will feature a streamlined version of the website that provides tailored information and content for YBLMT. This follows the design of HMP 1.0 where control arm participants had access to HIV-related Knowledge Center articles of the main intervention without access to the engagement features, interactive forums, or doctor Q&A. HIV-negative and sero-unknown participants also will be able to request HIV home test kits. The choice of control arm balances equipoise with research study design; in HMP 1.0, control arm participants also experienced a statistically significant intervention benefit.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Social Support

2022

Completed Phase 2

~3440

HIV Testing

2015

N/A

~860

Information Resources

2020

N/A

~750

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,879,338 Total Patients Enrolled

University of North CarolinaOTHER

166 Previous Clinical Trials

1,448,857 Total Patients Enrolled

Duke UniversityOTHER

2,359 Previous Clinical Trials

3,419,559 Total Patients Enrolled

Media Library

HIV Testing Clinical Trial Eligibility Overview. Trial Name: NCT03678181 — N/A

Human Immunodeficiency Virus Infection Research Study Groups: Information-Only Arm, HMP 2.0 Arm, Peer-referred HMP network arm

Human Immunodeficiency Virus Infection Clinical Trial 2023: HIV Testing Highlights & Side Effects. Trial Name: NCT03678181 — N/A

HIV Testing 2023 Treatment Timeline for Medical Study. Trial Name: NCT03678181 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I qualified to participate in this experiment?

"This medical trial seeks to enrol 1050 adolescents and young adults who are HIV-positive, have a Black/African American or Latino/Hispanic ethnicity, U.S residency (verified by zip code), report of at least one occurrence of unprotected anal intercourse in the preceding 6 months, an assigned male sex at birth, identification as either male or female gender identity and possess internet access alongside regular utilisation of a smartphone device or laptop/tablet with which they can log into the study website."

Answered by AI

How many patients are participating in this trial?

"Affirmative, the clinicaltrials.gov website reveals that this medical investigation is recruiting participants with a starting date of July 7th 2020 and an updated version on January 19th 2022. The trial needs 1050 individuals from 3 locations to participate in it."

Answered by AI

Does this research include participants aged 60 and above?

"This medical trial is exclusive to individuals between 15 and 29 years of age. For those younger or older than this range, there are 122 studies available for patients under 18 and 381 trials suitable for people over 65."

Answered by AI

Are there any vacancies in this medical experiment for potential participants?

"Affirmative. The clinical trial is advertised on clinicialtrials.gov and still looking for participants; the listing was first posted in July 2020 and edited lastly in January of 2022, with a total goal to recruit 1050 patients from 3 different sites."

Answered by AI

Recent research and studies

JMIR Research ProtocolsJournal

Increasing HIV Testing and Viral Suppression via Stigma Reduction in a Social Networking Mobile Health Intervention Among Black and Latinx Young Men and Transgender Women Who Have Sex with Men (healthmpowerment): Protocol for a Randomized Controlled Trial

Muessig, Kathryn Elizabeth, Jesse M Golinkoff, Lisa B Hightow-Weidman, Aimee E Rochelle, Marta I Mulawa, Sabina Hirshfield, A Lina Rosengren, et al.. 2020. “Increasing HIV Testing and Viral Suppression via Stigma Reduction in a Social Networking Mobile Health Intervention Among Black and Latinx Young Men and Transgender Women Who Have Sex with Men (healthmpowerment): Protocol for a Randomized Controlled Trial”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/24043.

clinicaltrials.govStudy

Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment

2020. "Increasing Engagement and Improving HIV Outcomes Via HealthMPowerment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03678181.